Banning sale of flavored e-cigarettes and traditional cigarettes may reduce interest smoking in the teen population.
Category: Forbes
DeepMind Is Handing Over DeepMind Health To Google
DeepMind Health will become part of Google Health in a move that raises fresh questions about the privacy of sensitive patient medical records.
A Sneak Peek At CES 2019: Same Footprint, More Technology Startups, New Resilience Area
At a media luncheon in San Francisco, the organizers of the Consumer Electronics Show gave me a sneak preview of CES 2019 which will have the same “footprint” as the previous show with about 2.75M square feet of exhibit space, over 180K attendees and 4…
Tesla’s Board Chair Change: Its Broader Relevance
Maybe a full time board chairman is good for your company too.
Large-Scale M&A Faces Capitol Commotion After U.S. Elections
Big deals that may have once cleared U.S. regulatory reviews face a murkier future with a Democratic House majority and the Trump administration’s skeptical posture toward consolidation.
Oscar Health Accuses Florida Blues Plan Of Broker Monopoly
Oscar Health is accusing health insurer Florida Blue of forcing brokers to sell its policies and hurting the ability of consumers to make more affordable choices.
Top 8 Healthcare Predictions for 2019
We have been writing the predictions for healthcare for the past 10 yrs.We also review back how we did each year and each year we are getting to be more accurate.The 2018 predictions that were released in Dec.2017 were almost 98% accurate and each one …
Medicare Costs Drop As Humana Shifts Doctors To Value-Based Models
Medical costs were 15.6% lower for seniors enrolled in Humana Medicare Advantage plans that paid physicians via value-based models last year, the insurer said.
Short-Term Insurance Plans Offer a Much-Needed Escape from Obamacare
Consumers should be free to choose the health plans that best meet their own financial and health needs. For millions of Americans, that means affordable, no-frills short-term coverage.
Novartis’ $4 Million Gene Therapy — Real Price Or A Negotiation Ploy?
We are in a wondrous age of medicine where CURES for certain types of cancer, rare diseases, blindness and other scourges are imminent. We now need to figure out how to pay for them.
